β-Endorphin omission analogs

Dissociation of immunoreactivity from other biological activities

C. H. Li, D. Yamashiro, L. Tseng, W. C. Chang, P. Ferrara

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

An analog of human β-endorphin with omission of four residues at positions 11, 14, 20, and 22 has been synthesized. This analog and other synthetic analogs with deletion of a single amino acid at position 2, 5, 6, 10, 11, 12, 13, 15, or 22 have been assayed for analgesic potency, ileal opiate activity, opiate receptor-binding activity, and immunoreactivity. Results show that deletion of a single amino acid of the β-endorphin molecule outside of the enkephalin segment to give (des-Gln11-, des-Thr:12-, des-Pro13-, des-Leu14-, des-Val15-, des-Asn20-, des- Ile22-β-endorphin) markedly reduced or abolished the immunoreactivity yet gave substantial retention of opiate potencies. Deletion of a single amino acid of β-endorphin within the enkephalin segment (des-Gly2- or des-Met5-β-endorphin) did not markedly affect the immunoactivity; however, the opiate activities were abolished or markedly reduced. The data indicate a clear dissociation of immunoactivity from analgesic, ileal-opiate, and opiate receptor-binding activities.

Original languageEnglish
Pages (from-to)3211-3214
Number of pages4
JournalProceedings of the National Academy of Sciences of the United States of America
Volume77
Issue number6 I
DOIs
Publication statusPublished - Dec 1 1980
Externally publishedYes

Fingerprint

Opiate Alkaloids
Endorphins
Enkephalins
Opioid Receptors
Amino Acids
Analgesics

ASJC Scopus subject areas

  • General

Cite this

β-Endorphin omission analogs : Dissociation of immunoreactivity from other biological activities. / Li, C. H.; Yamashiro, D.; Tseng, L.; Chang, W. C.; Ferrara, P.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 77, No. 6 I, 01.12.1980, p. 3211-3214.

Research output: Contribution to journalArticle

@article{817cbd3dfb2047b4a039858884aae77c,
title = "β-Endorphin omission analogs: Dissociation of immunoreactivity from other biological activities",
abstract = "An analog of human β-endorphin with omission of four residues at positions 11, 14, 20, and 22 has been synthesized. This analog and other synthetic analogs with deletion of a single amino acid at position 2, 5, 6, 10, 11, 12, 13, 15, or 22 have been assayed for analgesic potency, ileal opiate activity, opiate receptor-binding activity, and immunoreactivity. Results show that deletion of a single amino acid of the β-endorphin molecule outside of the enkephalin segment to give (des-Gln11-, des-Thr:12-, des-Pro13-, des-Leu14-, des-Val15-, des-Asn20-, des- Ile22-β-endorphin) markedly reduced or abolished the immunoreactivity yet gave substantial retention of opiate potencies. Deletion of a single amino acid of β-endorphin within the enkephalin segment (des-Gly2- or des-Met5-β-endorphin) did not markedly affect the immunoactivity; however, the opiate activities were abolished or markedly reduced. The data indicate a clear dissociation of immunoactivity from analgesic, ileal-opiate, and opiate receptor-binding activities.",
author = "Li, {C. H.} and D. Yamashiro and L. Tseng and Chang, {W. C.} and P. Ferrara",
year = "1980",
month = "12",
day = "1",
doi = "10.1073/pnas.77.6.3211",
language = "English",
volume = "77",
pages = "3211--3214",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
publisher = "National Academy of Sciences",
number = "6 I",

}

TY - JOUR

T1 - β-Endorphin omission analogs

T2 - Dissociation of immunoreactivity from other biological activities

AU - Li, C. H.

AU - Yamashiro, D.

AU - Tseng, L.

AU - Chang, W. C.

AU - Ferrara, P.

PY - 1980/12/1

Y1 - 1980/12/1

N2 - An analog of human β-endorphin with omission of four residues at positions 11, 14, 20, and 22 has been synthesized. This analog and other synthetic analogs with deletion of a single amino acid at position 2, 5, 6, 10, 11, 12, 13, 15, or 22 have been assayed for analgesic potency, ileal opiate activity, opiate receptor-binding activity, and immunoreactivity. Results show that deletion of a single amino acid of the β-endorphin molecule outside of the enkephalin segment to give (des-Gln11-, des-Thr:12-, des-Pro13-, des-Leu14-, des-Val15-, des-Asn20-, des- Ile22-β-endorphin) markedly reduced or abolished the immunoreactivity yet gave substantial retention of opiate potencies. Deletion of a single amino acid of β-endorphin within the enkephalin segment (des-Gly2- or des-Met5-β-endorphin) did not markedly affect the immunoactivity; however, the opiate activities were abolished or markedly reduced. The data indicate a clear dissociation of immunoactivity from analgesic, ileal-opiate, and opiate receptor-binding activities.

AB - An analog of human β-endorphin with omission of four residues at positions 11, 14, 20, and 22 has been synthesized. This analog and other synthetic analogs with deletion of a single amino acid at position 2, 5, 6, 10, 11, 12, 13, 15, or 22 have been assayed for analgesic potency, ileal opiate activity, opiate receptor-binding activity, and immunoreactivity. Results show that deletion of a single amino acid of the β-endorphin molecule outside of the enkephalin segment to give (des-Gln11-, des-Thr:12-, des-Pro13-, des-Leu14-, des-Val15-, des-Asn20-, des- Ile22-β-endorphin) markedly reduced or abolished the immunoreactivity yet gave substantial retention of opiate potencies. Deletion of a single amino acid of β-endorphin within the enkephalin segment (des-Gly2- or des-Met5-β-endorphin) did not markedly affect the immunoactivity; however, the opiate activities were abolished or markedly reduced. The data indicate a clear dissociation of immunoactivity from analgesic, ileal-opiate, and opiate receptor-binding activities.

UR - http://www.scopus.com/inward/record.url?scp=0019307831&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019307831&partnerID=8YFLogxK

U2 - 10.1073/pnas.77.6.3211

DO - 10.1073/pnas.77.6.3211

M3 - Article

VL - 77

SP - 3211

EP - 3214

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 6 I

ER -